BDX · Becton Dickinson & Co · Executive Compensation

$195.20 -1.20 (-0.61%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$53.49B

272.39M

Volume · Oct 27 295.45K Avg daily vol (3M) 1.75M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person	Role	Change	Effective	Filed
Michael D. Garrison	Executive Vice President and President of the Medical Essentials and BioPharma Systems segments	Retired	2026-10-02	2026-07-22
Michael D. Garrison	Executive Vice President and President of the Medical Essentials and BioPharma Systems segments	Retired	—	2026-07-22
Claire M. Fraser, Ph.D.	Waters Corporation Board of Directors	Appointed	—	2026-02-09
Claire M. Fraser, Ph.D.	director of the Company	Resigned	2026-02-09	2026-02-09
Jacqueline Wright	Board of Directors	Appointed	2025-12-01	2025-11-17
Robert L. Huffines	Board of Directors	Appointed	2025-12-01	2025-11-17
Christopher J. DelOrefice	Executive Vice President and Chief Financial Officer	Resigned	2025-12-05	2025-10-15
Gregory J. Hayes	Board of Directors	Appointed	2025-03-26	2025-03-27
Pamela L. Spikner	Senior Vice President, Chief Accounting Officer and Controller	Appointed	2025-01-20	2025-01-10
Christopher DelOrefice	principal accounting officer	Appointed	2024-08-30	2024-08-30
Thomas Spoerel	principal accounting officer	Resigned	2024-08-30	2024-08-30
Thomas Spoerel	Senior Vice President, CFO Regions	Appointed	2024-08-30	2024-08-30
David Hickey	Executive Vice President and President of the Life Sciences segment	Retired	2024-07-01	2024-02-27
Dr. Joanne Waldstreicher	member of the Board of Directors	Appointed	2023-07-24	2023-07-24
Michelle Quinn	acting general counsel	Appointed	—	2023-01-06
Richard Byrd	Executive Vice President and President, Interventional Segment	Appointed	2022-09-06	2022-08-25
Michael Garrison	Executive Vice President and President, Medical Segment	Appointed	2022-09-06	2022-08-25

Leadership

David F. Melcher Chairman
Thomas E. Polen Chairman, Board Member
Patrick K. Kaltenbach CTO
Michelle Quinn General Counsel
Christopher DelOrefice Chief Accounting Officer
Pamela L. Spikner Chief Accounting Officer
Bertram L. Scott Board Member
Carrie L. Byington Board Member
Carrie L. Byington, M.D. Board Member
Christopher Jones Board Member
Claire M. Fraser, Ph.D. Board Member
Claire Pomeroy Board Member
Dr. Joanne Waldstreicher Board Member
Gregory J. Hayes Board Member
Jacqueline Wright Board Member
Jeffrey W. Henderson Board Member
Joanne Waldstreicher Board Member
R. Andrew Eckert Board Member
Robert L. Huffines Board Member
Thomas Polen Board Member
Timothy M. Ring Board Member
William M. Brown Board Member

Key facts CIK 10795 CUSIP 075887109 13F (30d) 442 filings 423 filers Visit website Investor relations